000 01187 a2200361 4500
005 20250512013252.0
264 0 _c19891215
008 198912s 0 0 eng d
022 _a0172-8172
024 7 _a10.1007/BF00270248
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHauzeur, J P
245 0 0 _aDouble-blind, placebo-controlled study of OM-8980 in rheumatoid arthritis.
_h[electronic resource]
260 _bRheumatology international
_c1989
300 _a71-6 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aAdjuvants, Immunologic
_xadverse effects
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntigens, Bacterial
650 0 4 _aArthritis, Rheumatoid
_xdrug therapy
650 0 4 _aClinical Trials as Topic
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Tolerance
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
700 1 _aAppelboom, T
773 0 _tRheumatology international
_gvol. 9
_gno. 2
_gp. 71-6
856 4 0 _uhttps://doi.org/10.1007/BF00270248
_zAvailable from publisher's website
999 _c2688858
_d2688858